Industries > Pharma > Global Blood Cancer Market Forecast to 2028

Global Blood Cancer Market Forecast to 2028

Immunotherapy, Chemotherapy, Targeted Therapy

PUBLISHED: 11 April 2019
PAGES: 92
PRODUCT CODE: PHA0412
SUBMARKET: Therapeutic Drugs

Clear
WOOCS 2.2.1
DOWNLOAD SAMPLE
SKU: PHA0412 Categories: , Tags: , , , , ,

The global blood cancer market reached $24bn in 2018 and is estimated to grow at a CAGR of 6.4% in the first half of the forecast period. Chemotherapy held 44% of the market in 2018.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand-new report you will receive 61 charts – all unavailable elsewhere.

This report provides clear detailed insight into the global blood cancer market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope

• Revenue and growth forecasts to 2028 for the blood cancer market

• Revenue and growth forecast to 2028 for the blood cancer market by type of therapy:
• Chemotherapy
• Targeted therapy
• Immunotherapy

• Revenue and growth forecast to 2028 for the blood cancer market by regional and national market:
• The US
• Japan
• Germany
• France
• The UK
• Spain
• Italy
• Brazil
• Russia
• India
• China

Global Blood Cancer Market Forecast to 2028

For each national market, the revenue forecast is also broken down by submarket.

• For each national market, this report provides incident cases projection from 2018 to 2028 for:
• Leukaemia
• Non-Hodgkin Lymphoma
• Hodgkin Lymphoma
• Multiple Myeloma

• Discussion and profiles of the leading players in the blood cancer market:
• Amgen
• AstraZeneca
• Bayer
• Bristol-Myers Squibb (BMS)
• Celgene
• Johnson & Johnson
• Novartis
• Pfizer
• Roche

• Discussion on drugs that are currently in the R&D pipeline for Leukaemia, Lymphoma and Multiple Myeloma.

• Analysis of what stimulates and restrains the global blood cancer market: Porter’s Five Forces Analysis, Trends, Drivers and Challenges

• Key Questions Answered by this Report:
• How is the Blood Cancer market evolving?
• What are the drivers and restraints for the growth of the Blood Cancer market?
• How will each Blood Cancer submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2028?
• What will be the main driver for the overall market to 2028?
• How will political and regulatory factors influence the regional markets and submarkets?
• Will leading national Blood Cancer markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
• How will the market shares of the national markets change by 2028 and which geographical region will lead the market in 2028?
• Who are the leading players and what are their prospects over the forecast period?

Visiongain’s study is intended for anyone requiring commercial analyses for the global blood cancer market. You find data, trends and predictions.

Buy our report today Global Blood Cancer Market Forecast to 2028: Immunotherapy, Chemotherapy, Targeted Therapy.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for Global Blood Cancer Market Forecast to 2028


Download sample pages

Complete the form below to download your free sample pages for Global Blood Cancer Market Forecast to 2028


Latest Pharma news

“Global Human Microbiome Therapeutics market set to grow to $1.6bn” by 2025 says new Visiongain report

The market for microbiome therapeutics is expected to commence around mid-2020 with the launch of new products relating to dermatology and gastrointestinal disorders.

04 December 2019

READ

“Global Next-Generation Biologics market set to grow to $42bn by 2024” says new Visiongain report

Technological developments in the next-generation biologics market will be the result of clinical development of multiple platforms in the next-generation antibody, antibody fragment and ALP sectors.

04 December 2019

READ

“Global Liquid Biopsy market set to grow to $4.9bn by 2024” says new Visiongain report

The main drivers for the growth include technological advancements such as development of novel biomarkers, rising preference for minimally or less invasive surgeries, increasing cancer awareness leading to growth in cancer cases, and growing disposable income in emerging economies.

04 December 2019

READ

“Global nucleic acid isolation and purification market is anticipated to reach USD 8.16 Billion by 2030”, says Visiongain

Nucleic acid separation and purification is one of modern science and technology’s most complex and critical accomplishments.

29 November 2019

READ

Categories

Category